Take (BOM:532890) Total Operating Expense: ₹22.3 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532890 Take Ltd BOM:532890
31 GF Score
Price ₹20.86
! 3 Warning Signs
View Full Analysis

What is Take Total Operating Expense?

Take BOM:532890 +0.48% 31 Total Operating Expense is ₹22.3 Mil as of Mar. 2026. GuruFocus rates BOM:532890 with a GF Score™ of 31/100. The stock has 3 warning signs investors should review.

Take's Total Operating Expense for the three months ended in Mar. 2026 was ₹8.1 Mil. Take's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹22.3 Mil.

Take Total Operating Expense Related Terms

Take Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Take's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Take Total Operating Expense Chart

Take Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,199.00 1,002.40 69.74 75.20 19.08

Take Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.48 7.76 2.95 3.51 8.11
BOM:532890
31GF Score
Take Ltd BOM:532890
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Take Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹22.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹22.3 Mil mean?
Take (BOM:532890) has a Total Operating Expense of ₹22.3 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Take and its competitors.
Is Take's Total Operating Expense too high?
Take's current Total Operating Expense is ₹22.3 Mil. Overall, Take has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Take's Total Operating Expense compare to VEEV and BTSG?
Take's Total Operating Expense of ₹22.3 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Healthcare Providers & Services company?
A good Total Operating Expense depends on the Healthcare Providers & Services industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Take and its competitors. Take's current Total Operating Expense is ₹22.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Take stock overvalued right now?
Take (BOM:532890) has a current Total Operating Expense of ₹22.3 Mil. The current Total Operating Expense is ₹22.3 Mil. Take's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Take (BOM:532890), the current Total Operating Expense is ₹22.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Take Business Description

Other Exchanges TAKE:India
Address No.56, Old No. 116, Dr. Radhakrishnan Salai, 4th Floor, Ragas Building, Mylapore, Chennai, TN, IND, 600004
Take Solutions Ltd is a technology solutions provider specializing in Life Sciences and Supply Chain Management services. The company offers integrated services including clinical research, generics support, regulatory affairs, pharmacovigilance, and data sciences. It supports pharmaceutical, biotech, and medical device companies to various countries with technology-backed solutions that enhance drug development and regulatory compliance. Revenue is driven by its broad portfolio of IT-enabled services focused on the life sciences industry and supply chain management, catering to a client base of innovators, generics manufacturers, and biotech firms.
31GF Score

Get the complete analysis for BOM:532890

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹20.86
Price